TITLE:
Post-Vaccination Myasthenia Gravis and Vaquez Disease
AUTHORS:
Alassane Mamadou Diop, Ahmadou Bamba Mbodj, Daouda Thioub, Jamil Kawahgi, Maouly Fall
KEYWORDS:
SARS-CoV2, Myasthenia, JAK2
JOURNAL NAME:
Neuroscience and Medicine,
Vol.16 No.2,
June
25,
2025
ABSTRACT: We report the case of a 68-year-old patient who developed autoimmune myasthenia 24 hours after receiving the second dose of an inactivated SARS-CoV-2 vaccine (Sinopharm®). This patient, already followed for ischemic heart disease, presented with typical symptoms such as diplopia, bilateral ptosis, and muscle fatigability upon exertion. Investigations revealed the presence of anti-acetylcholine receptor antibodies as well as polycythemia, confirmed by the JAK2 V617F mutation, suggesting an association with a myeloproliferative disorder.